A detailed history of Artal Group S.A. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Artal Group S.A. holds 3,330,422 shares of IGMS stock, worth $59.4 Million. This represents 1.45% of its overall portfolio holdings.

Number of Shares
3,330,422
Previous 3,080,422 8.12%
Holding current value
$59.4 Million
Previous $29.7 Million 23.03%
% of portfolio
1.45%
Previous 1.6%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.51 - $11.47 $1.63 Million - $2.87 Million
250,000 Added 8.12%
3,330,422 $22.9 Million
Q1 2024

May 13, 2024

SELL
$8.68 - $17.36 $173,600 - $347,200
-20,000 Reduced 0.65%
3,080,422 $29.7 Million
Q4 2023

Feb 09, 2024

BUY
$3.94 - $8.79 $2.28 Million - $5.08 Million
578,178 Added 22.92%
3,100,422 $25.8 Million
Q2 2023

Aug 11, 2023

BUY
$8.86 - $14.0 $108,729 - $171,808
12,272 Added 0.49%
2,522,244 $23.3 Million
Q1 2023

May 12, 2023

BUY
$13.74 - $25.76 $824,015 - $1.54 Million
59,972 Added 2.45%
2,509,972 $34.5 Million
Q3 2022

Nov 14, 2022

BUY
$15.42 - $27.01 $6.94 Million - $12.2 Million
450,000 Added 22.5%
2,450,000 $55.7 Million
Q1 2022

May 12, 2022

BUY
$13.42 - $29.73 $6.71 Million - $14.9 Million
500,000 Added 33.33%
2,000,000 $53.5 Million
Q4 2021

Feb 11, 2022

BUY
$27.59 - $66.39 $4.14 Million - $9.96 Million
150,000 Added 11.11%
1,500,000 $44 Million
Q3 2021

Nov 12, 2021

BUY
$65.76 - $90.65 $16.4 Million - $22.7 Million
250,000 Added 22.73%
1,350,000 $88.8 Million
Q2 2021

Aug 13, 2021

SELL
$57.98 - $96.6 $1.45 Million - $2.42 Million
-25,000 Reduced 2.22%
1,100,000 $91.5 Million
Q1 2021

May 14, 2021

SELL
$71.56 - $121.23 $5.37 Million - $9.09 Million
-75,000 Reduced 6.25%
1,125,000 $86.3 Million
Q4 2020

Feb 11, 2021

BUY
$47.41 - $115.03 $24.2 Million - $58.8 Million
511,090 Added 74.19%
1,200,000 $106 Million
Q3 2020

Nov 13, 2020

BUY
$43.0 - $84.01 $29.6 Million - $57.9 Million
688,910 New
688,910 $50.8 Million
Q1 2020

May 14, 2020

SELL
$31.51 - $73.75 $4.73 Million - $11.1 Million
-150,000 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$17.25 - $49.51 $862,500 - $2.48 Million
-50,000 Reduced 25.0%
150,000 $5.72 Million
Q3 2019

Nov 14, 2019

BUY
$17.75 - $24.3 $3.55 Million - $4.86 Million
200,000 New
200,000 $3.55 Million

Others Institutions Holding IGMS

About IGM Biosciences, Inc.


  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $517M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Artal Group S.A. Portfolio

Follow Artal Group S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.